| related words |
| orphan |
| hematide |
| soliris |
| tarceva |
| recothrom |
| feraheme |
| investigational |
| novel |
| surgeon |
| gene |
| stem |
| antibody |
| molecular |
| increlex |
| halted |
| stent |
| premarket |
| dacogen |
| krystexxa |
| clearant |
|
| related documents |
| 1012140--3/16/2006--ONYX_PHARMACEUTICALS_INC |
| 1012140--2/29/2008--ONYX_PHARMACEUTICALS_INC |
| 1012140--3/5/2007--ONYX_PHARMACEUTICALS_INC |
| 1012140--2/23/2010--ONYX_PHARMACEUTICALS_INC |
| 1012140--2/25/2009--ONYX_PHARMACEUTICALS_INC |
|
| related topics |
| {product, liability, claim} |
| {product, candidate, development} |
| {control, financial, internal} |
| {operation, natural, condition} |
| {property, intellectual, protect} |
| {provision, law, control} |
| {investment, property, distribution} |
| {interest, director, officer} |
| {acquisition, growth, future} |
| {regulation, change, law} |
| {operation, international, foreign} |
| {loan, real, estate} |
| {stock, price, share} |
| {cost, operation, labor} |
| {loss, insurance, financial} |
| {capital, credit, financial} |
| {competitive, industry, competition} |
| {product, market, service} |
| {customer, product, revenue} |
| {debt, indebtedness, cash} |
|